Aurinia Pharmaceuticals: Highlighting An Important Clinical And Regulatory Change Seeking Alpha, 28 Mar 2017 Company Synopsis Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH ) is a late stage biopharmaceutical company whose primary focus is…